Daniela Furlan

10PUBLICATIONS

36CO-AUTHORS

Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer genetics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|May 12, 2026

Molecular Profiling of Digestive Grade 3 Neuroendocrine Tumors Reveals a Shared Molecular Framework with Lower-Grade Tumors, Marked Heterogeneity, and Therapeutic Opportunities.

|Nov 27, 2024

LINE-1 hypomethylation characterizes the inflammatory response in coeliac disease associated-intestinal mucosa and small bowel adenocarcinomas.

Laura Libera, Alessandro Vanoli, Nora Sahnane

|Aug 28, 2024

Medullary carcinomas of the nonampullary small intestine: association with coeliac disease, mismatch repair deficiency, PD-L1 expression, and favourable prognosis.

Alessandro Vanoli, Federica Grillo, Giuseppe De Lisi

|Aug 26, 2022

Tumor Antigenicity and a Pre-Existing Adaptive Immune Response in Advanced BRAF Mutant Colorectal Cancers.

Elena Bolzacchini, Laura Libera, Sarah E Church

|Oct 13, 2021

Methylation Drivers and Prognostic Implications in Sinonasal Poorly Differentiated Carcinomas.

Laura Libera, Giorgia Ottini, Nora Sahnane

|Apr 30, 2021

MYD88<sup>L265P</sup> Detection in IgM Monoclonal Gammopathies: Methodological Considerations for Routine Implementation.

Martina Ferrante, Daniela Furlan, Silvia Zibellini

Pageof 2

Frequent Collaborators

Laura Libera

Catherine Klersy

Antonio Di Sabatino

Silvia Uccella

Stefano La Rosa

Alessandro Vanoli

Carolina Ciacci

Anna Maria Chiaravalli

1 joint publications

Nora Sahnane

1 joint publications

Ian Tomlinson

Frequent Collaborators

Laura Libera

Catherine Klersy

Antonio Di Sabatino

Silvia Uccella